Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.scr.2008.07.004
DC FieldValue
dc.titleDerivation of functional insulin-producing cell lines from primary mouse embryo culture
dc.contributor.authorLi, G.D.
dc.contributor.authorLuo, R.
dc.contributor.authorZhang, J.
dc.contributor.authorXie, F.
dc.contributor.authorLim, S.K.
dc.contributor.authorSalto-Tellez, M.
dc.contributor.authorYeo, K.S.
dc.contributor.authorWay, Tan E.K.
dc.contributor.authorCaille, D.
dc.contributor.authorMeda, P.
dc.contributor.authorQue, J.
dc.contributor.authorKon, O.L.
dc.date.accessioned2012-01-30T09:44:59Z
dc.date.available2012-01-30T09:44:59Z
dc.date.issued2009
dc.identifier.citationLi, G.D., Luo, R., Zhang, J., Xie, F., Lim, S.K., Salto-Tellez, M., Yeo, K.S., Way, Tan E.K., Caille, D., Meda, P., Que, J., Kon, O.L. (2009). Derivation of functional insulin-producing cell lines from primary mouse embryo culture. Stem Cell Research 2 (1) : 29-40. ScholarBank@NUS Repository. https://doi.org/10.1016/j.scr.2008.07.004
dc.identifier.issn18735061
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/30147
dc.description.abstractWe have previously described the derivation of insulin-producing cell lines from mouse embryonic stem cells (mESCs) by differentiation of an intermediate lineage-restricted E-RoSH cell line through nutrient depletion in the presence of nicotinamide followed by limiting dilution. Here we investigated whether insulin-producing cell lines could be similarly derived directly from mouse embryo cells or tissues. Using a similar approach, we generated the RoSH2.K and MEPI-1 to -14 insulin-producing cell lines from the 5.5-dpc embryo-derived E-RoSH-analogous RoSH2 cell line and a 6.0-dpc mouse embryo culture, respectively. Insulin content was ∼8 μg/106 MEPI-1 cells and 0.5 μg/106 RoSH2.K cells. Like insulin-producing mESC-derived ERoSHK cell lines, both MEPI and RoSH2.K lines were amenable to repeated cycles of freeze and thaw, replicated for months with a doubling time of 3-4 days, and exhibited genomic, structural, biochemical, and pharmacological properties of pancreatic β-cells, including storage and release of insulin and C-peptide in an equimolar ratio. Transplantation of these cells also reversed hyperglycemia in streptozotocin-treated SCID mice and did not induce teratoma. Like ERoSHK cells, both RoSH2.K and MEPI-1 cells also induced hypoglycemia in the mice. Therefore, our protocol is robust and could reproducibly generate insulin-producing cell lines from different embryonic cell sources. © 2008 Elsevier B.V. All rights reserved.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.scr.2008.07.004
dc.sourceScopus
dc.typeArticle
dc.contributor.departmentBIOCHEMISTRY
dc.contributor.departmentSURGERY
dc.contributor.departmentNATIONAL UNIVERSITY MEDICAL INSTITUTES
dc.description.doi10.1016/j.scr.2008.07.004
dc.description.sourcetitleStem Cell Research
dc.description.volume2
dc.description.issue1
dc.description.page29-40
dc.identifier.isiut000269909000005
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.